<DOC>
	<DOCNO>NCT00115193</DOCNO>
	<brief_summary>The purpose study provide data safety efficacy pegfilgrastim administer day versus next day chemotherapy , measure duration grade 4 neutropenia .</brief_summary>
	<brief_title>Pegfilgrastim Administered Same Day Chemotherapy Non-Hodgkin 's Lymphoma</brief_title>
	<detailed_description>This multicenter , double-blind , randomize , phase 2 study pegfilgrastim give either day day chemotherapy regimen consist cyclophosphamide , doxorubicin , vincristine , prednisone , rituximab ( R-CHOP ) . Chemotherapy administer every 21 day 6 cycle subject aggressive non-Hodgkin 's lymphoma ( NHL ; mantle cell diffuse large B-cell lymphoma ) . Subjects administer R-CHOP day 1 cycle . All subject randomize 1 2 treatment arm : arm A subject administer pegfilgrastim 6 mg day 1 cycle ( within 4 hour chemotherapy completion ) ; arm B subject administer pegfilgrastim 6 mg day 2 cycle ( least 24 hour chemotherapy completion ) . All subject administer placebo day receive pegfilgrastim . A total 77 subject enrol 24 center across US . Protocol treatment duration subject 18 week ( 6 three-week cycle ) .</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , Non-Hodgkin</mesh_term>
	<criteria>Histologically proven mantle cell lymphoma histologically prove diffuse large Bcell nonHodgkin 's lymphoma ( NHL ) accord REAL classification Measurable and/or evaluable disease Previously untreated patient Burkitt 's Blymphoblastic lymphoma Central nervous system ( CNS ) involvement Active infection require treatment systemic antiinfectives within 72 hour chemotherapy Prior malignancy within last 5 year Tcell lymphoma history indolent lymphoma Prior bone marrow stem cell transplantation Known sensitivity E. coli derive drug product</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>Oncology</keyword>
	<keyword>NHL</keyword>
	<keyword>Mantle cell</keyword>
	<keyword>Diffuse large B-cell</keyword>
	<keyword>Chemotherapy</keyword>
	<keyword>RCHOP</keyword>
	<keyword>NeulastaÂ®</keyword>
	<keyword>Neutropenia</keyword>
	<keyword>Pegfilgrastim</keyword>
	<keyword>Amgen</keyword>
</DOC>